Aurigene Oncology Profile
Key Indicators
- Authorised Capital ₹ 240.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 187.56 Cr
as on 08-12-2024
- Company Age 23 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.59 Cr
as on 08-12-2024
- Revenue -4.29%
(FY 2022)
- Profit -44.97%
(FY 2022)
- Ebitda -46.97%
(FY 2022)
- Net Worth -42.51%
(FY 2022)
- Total Assets -37.46%
(FY 2022)
About Aurigene Oncology
The Corporate was formerly known as Aurigene Discovery Technologies P Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 240.00 Cr and a paid-up capital of Rs 187.56 Cr.
The company has closed loans amounting to ₹6.59 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aurigene Oncology Limited India are Varun Challapalli as Company Secretary, Brijesh Karnani as Cfo, and Muralidhara Ramachandra as Ceo. Venkateswara Gunupati, Satish Kallam, Bruce Carter, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24239KA2001PLC029391
- Company No.
029391
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2001
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aurigene Oncology Limited offer?
Aurigene Oncology Limited offers a wide range of products and services, including Project Feasibility Studies, Market Research Service, Licensing Services, Import Licensing Services, Pharmaceutical Services, Biotechnology Services, Fertilizer, Amino Acids, DGFT Licensing, Welfare Organization Services.
Who are the key members and board of directors at Aurigene Oncology?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Challapalli | Company Secretary | 20-Feb-2024 | Current |
| Brijesh Karnani | CFO | 26-Mar-2020 | Current |
Muralidhara Ramachandra  | CEO | 01-Jul-2019 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satish Kallam | Director | 10-Aug-2001 | Current |
| Venkateswara Gunupati | Director | 10-Aug-2001 | Current |
Bruce Carter  | Director | 30-Mar-2015 | Current |
| Venkata Motupalli | Director | 19-Oct-2023 | Current |
| Shubhada Chiplunkar | Director | 01-Oct-2022 | Current |
| Kumar Srinivasan | Director | 01-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Aurigene Oncology.
Aurigene Oncology Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.29% decrease. The company also saw a substantial fall in profitability, with a 44.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurigene Oncology?
In 2023, Aurigene Oncology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr.Reddy's Institute Of Life SciencesActive 21 years 1 monthVenkateswara Gunupati and Satish Kallam are mutual person
Greenpark Hotels And Resorts LimitedActive 38 years 22 daysVenkateswara Gunupati and Satish Kallam are mutual person
Stamlo Industries LimitedActive 28 years 7 monthsVenkateswara Gunupati and Satish Kallam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Sep 2011 | ₹6.50 Cr | Satisfied |
Icici Bank Limited Creation Date: 21 Oct 2005 | ₹0.88 M | Satisfied |
How Many Employees Work at Aurigene Oncology?
Aurigene Oncology has a workforce of 479 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurigene Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurigene Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
